MICROPORT CARDIO.MEDTECH. (72X) - Total Assets
Based on the latest financial reports, MICROPORT CARDIO.MEDTECH. (72X) holds total assets worth €2.67 Billion EUR (≈ $3.12 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See MICROPORT CARDIO.MEDTECH. (72X) net asset quality to measure how much of total assets are equity-financed.
MICROPORT CARDIO.MEDTECH. - Total Assets Trend (2021–2024)
This chart illustrates how MICROPORT CARDIO.MEDTECH.'s total assets have evolved over time, based on quarterly financial data. Check MICROPORT CARDIO.MEDTECH. (72X) tangible equity ratio to evaluate the tangible quality of the company's equity base.
MICROPORT CARDIO.MEDTECH. - Asset Composition Analysis
Current Asset Composition (December 2024)
MICROPORT CARDIO.MEDTECH.'s total assets of €2.67 Billion consist of 62.6% current assets and 37.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 4.0% |
| Accounts Receivable | €136.59 Million | 5.1% |
| Inventory | €135.38 Million | 5.1% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €192.28 Million | 7.2% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how MICROPORT CARDIO.MEDTECH.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MICROPORT CARDIO.MEDTECH. stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MICROPORT CARDIO.MEDTECH.'s current assets represent 62.6% of total assets in 2024, a decrease from 77.3% in 2021.
- Cash Position: Cash and equivalents constituted 4.0% of total assets in 2024, down from 65.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, unchanged from 7.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 7.2% of total assets.
MICROPORT CARDIO.MEDTECH. Competitors by Total Assets
Key competitors of MICROPORT CARDIO.MEDTECH. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
MICROPORT CARDIO.MEDTECH. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.94 | 7.60 | 7.60 |
| Quick Ratio | 6.50 | 7.13 | 7.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €1.46 Billion | €1.64 Billion | €1.64 Billion |
MICROPORT CARDIO.MEDTECH. - Advanced Valuation Insights
This section examines the relationship between MICROPORT CARDIO.MEDTECH.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.77 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | €2.68 Billion |
| Market Capitalization | $107.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values MICROPORT CARDIO.MEDTECH.'s assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: MICROPORT CARDIO.MEDTECH.'s assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for MICROPORT CARDIO.MEDTECH. (2021–2024)
The table below shows the annual total assets of MICROPORT CARDIO.MEDTECH. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €2.68 Billion ≈ $3.13 Billion |
+3.83% |
| 2023-12-31 | €2.58 Billion ≈ $3.01 Billion |
-14.13% |
| 2022-12-31 | €3.00 Billion ≈ $3.51 Billion |
-10.73% |
| 2021-12-31 | €3.36 Billion ≈ $3.93 Billion |
-- |
About MICROPORT CARDIO.MEDTECH.
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more